Neglected diseases such as malaria, tuberculosis and Chagas disease still afflict large populations in poor countries. The mission of Distributed Drug Discovery (D3) is to speed the development of drugs for neglected diseases by enabling global academic and research networks to simultaneously educate and innovate. Our D3 Hub provides a site to coordinate and facilitate research and educational collaborations.
Distributed Drug Discovery (D3) is an ambitious project to link basic researchers, funding agencies, communities, students, and teachers around the world in an effort to speed up the drug discovery process. Read More ...
D3 is committed to finding novel compounds as potential hits or leads for the treatment or cure of diseases afflicting populations in developing countries (neglected diseases) and worldwide (conventional diseases). Some of the diseases that D3 will target include:
- Chagas Disease
D3 uses an approach that establishes a tight link between:
- What molecules can be made (D3 virtual catalogs)
- What molecules should be made (from computational analyses of these D3 virtual catalogs)
- Synthesis of the selected molecules (via D3 educational networks) [Our equipment (PDF)]
- Evaluation of these molecules for potential activity against neglected disease targets (centralized or D3 based screening)